Landos Biopharma, Inc. , a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases.
Landos Biopharma stock last closed at $21.96, up 0.64% from the previous day, and has increased 681.22% in one year. It has overperformed other stocks in the Biotechnology industry by 7.04 percentage points. Landos Biopharma stock is currently +778.4% from its 52-week low of $2.50, and -0.61% from its 52-week high of $22.10.
There are currently 3.12M LABP shares outstanding. The market value of LABP is $68.44M. In the last 24 hours, 13,185 LABP shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy LABP shares.
We believe that eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro today.
Open eToro AccountNow that you've picked your brokerage, it's time to fill out some personal info so you can invest in LABP stock today.
Now that you have opened your account on the stock trading app, you can securely and quickly fund your account:
Check out the video below for more details depositing funds into your brokerage account.
Once you have figured out the best place to buy Landos Biopharma stock, it's absolutely critical to analyze their stock prior to buying, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on LABP's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge LABP's true value.
Using relative valuations metrics:
You can do additional valuation analysis on LABP's stock here.
Out of 1 sell side analysts who monitor LABP, the consensus analyst rating on LABP is a Hold
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Landos Biopharma stock forecast page.
Over the last 12 months, executives and large shareholders at LABP have not bought or sold any shares.
Get more info about who owns LABP shares here.
No, Landos Biopharma doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main order types:
Hit the Open Trade button and eToro will place your order.
If you need more help investing in stocks on eToro, watch the helpful video below:
Now that you own some LABP shares, you'll want to keep up with your company.
Make a watchlist to get notified of important updates regarding your LABP stock.
To summarize, here are the 6 steps to buy stock in Landos Biopharma:
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Landos Biopharma, add LABP to your watchlist below.